Thimerosal blocks stimulated but not basal release of endothelium‐derived relaxing factor (EDRF) in dog isolated coronary artery
Open Access
- 1 October 1992
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 107 (2) , 566-572
- https://doi.org/10.1111/j.1476-5381.1992.tb12784.x
Abstract
The effect of an acetly‐coA lysolecithin acyltransferase inhibitor, thimerosal, on the release of endothelium‐derived relaxing factor (EDRF) was examined in the greyhound isolated coronary artery. Thimerosal (1–10 μm) relaxed fully, ring segments of coronary artery which were contracted with the thromboxane A2‐mimetic, U46619 (30 nm). The response was endothelium‐dependent, slow in both onset and time to reach maximum. The maximum relaxation to the highest concentration of thimerosal (10 μm) was maintained for 10–20 min before the tissue slowly regained active force (1–2 h) to the same or higher level as that prior to the addition of thimerosal. At this time the endothelium‐dependent relaxation responses to acetylcholine (ACh), substance P (SP), bradykinin (BK) and the calcium ionophores, ionomycin and A23187 were abolished. The endothelium‐dependent contractions to the nitric oxide synthase inhibitors, NG‐nitro‐l‐arginine (l‐NNA; 10–100 μm) and NG‐monomethyl‐l‐arginine (l‐NMMA: 10–100 μm), however, were unaffected. Thimerosal (10 μm) did not affect the relaxation curve to sodium nitroprusside (SNP) nor the contraction curve to the thromboxane A2‐mimetic, U46619. Both the relaxation response to thimerosal and the selective block of the relaxation responses to stimulated EDRF release were unaffected by either indomethacin (10 μm) or superoxide dismutase (150 u ml−1). l‐NNA (100 μm) significantly blocked the relaxation curves to thimerosal and A23187 but not that to SNP.6 Abolition of stimulated EDRF‐mediated responses with thimerosal was unlikely to result from maximal and maintained stimulation of EDRF release even when active U46619‐induced force had returned to pre‐thimerosal levels, since the relaxation curves to glyceryl trinitrate (GTN) and SNP were markedly attenuated in the presence of SNP and GTN respectively when active force was restored with endothelin‐1 (ET‐1).7 Melittin (1 μm), ionomycin (1 μm) and A23187 (1 μm) each had selective effects on stimulated but not basal EDRF responses, similar to those of thimerosal.8 We propose that stimulated but not ‘basal’ release of EDRF is dependent on the release of arachidonic acid or one of its non‐cyclo‐oxygenase metabolites, possibly by Ca2+‐dependent activation of phospholipase A2.Keywords
This publication has 42 references indexed in Scilit:
- Melittin stimulates phosphoinositide hydrolysis and placental lactogen release: Arachidonic acid as a link between phospholipase A2 and phospholipase C signal-transduction pathwaysLife Sciences, 1991
- Evidence That Contractions of Isolated Arteries by l-NMMA and NOLA Are Not Due to Inhibition of Basal EDRF ReleaseJournal of Cardiovascular Pharmacology, 1991
- Establishment of a Human Cell Line Highly Expressing Endothelin in Serum-Free MediumJournal of Cardiovascular Pharmacology, 1991
- Endothelium-derived relaxing factorPharmacology & Therapeutics, 1989
- The sulfhydryl reagent thimerosal elicits human platelet aggregation by mobilization of intracellular calcium and secondary prostaglandin endoperoxide formationBiochemical and Biophysical Research Communications, 1989
- Role of calcium in endothelium-dependent relaxation of arterial smooth muscleThe American Journal of Cardiology, 1987
- EDRF: a Ca2+ -dependent chemical moiety(ies)Trends in Pharmacological Sciences, 1985
- Release and properties of endothelium‐derived relaxing factor (EDRF) from endothelial cells in cultureJournal of Cellular Physiology, 1985
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Bee and Wasp VenomsScience, 1972